» Articles » PMID: 26077968

Reduction of Acrylamide Level Through Blanching with Treatment by an Extremely Thermostable L-asparaginase During French Fries Processing

Overview
Journal Extremophiles
Publisher Springer
Date 2015 Jun 17
PMID 26077968
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Bacterial L-asparaginase catalyzes the hydrolysis of L-asparagine to L-aspartic acid. It is normally used as an antineoplastic drug applied in lymphoblastic leukemia chemotherapy and as a food processing aid in baked or fried food industry to inhibit the formation of acrylamide. The present study demonstrates cloning, expression, and characterization of a thermostable L-asparaginase from Thermococcus zilligii AN1 TziAN1_1 and also evaluates the potential for enzymatic acrylamide mitigation in French fries using this enzyme. The recombinant L-asparaginase was purified to homogeneity by nickel-affinity chromatography. The purified enzyme displayed the maximum activity at pH 8.5 and 90 °C, and the optimum temperature was the highest ever reported. The K m, k cat, and k cat/K m values toward L-asparagine were measured to be 6.08 mM, 3267 s(-1), and 537.3 mM(-1) s(-1), respectively. The enzyme retained 70 % of its original activity after 2 h of incubation at 85 °C. When potato samples were treated with 10 U/mL of L-asparaginase at 80 °C for only 4 min, the acrylamide content in final French fries was reduced by 80.5 % compared with the untreated control. Results of this study revealed that the enzyme was highly active at elevated temperatures, reflecting the potential of the T. zilligii L-asparaginase in the food processing industry.

Citing Articles

Recent advances in L-Asparaginase enzyme production and formulation development for acrylamide reduction during food processing.

Jana A, Biswas S, Ghosh R, Modak R Food Chem X. 2025; 25:102055.

PMID: 39758072 PMC: 11696629. DOI: 10.1016/j.fochx.2024.102055.


Identification of a thermostable L-asparaginase from Pyrococcus yayanosii CH1 and its application in the reduction of acrylamide.

Ni D, Xu W, Zhang W, Mu W Extremophiles. 2024; 28(3):44.

PMID: 39313567 DOI: 10.1007/s00792-024-01360-4.


L-Asparaginase Conjugates from the Hyperthermophilic Archaea with Improved Biocatalytic Properties.

Dobryakova N, Dumina M, Zhgun A, Pokrovskaya M, Aleksandrova S, Zhdanov D Int J Mol Sci. 2024; 25(8).

PMID: 38673759 PMC: 11050321. DOI: 10.3390/ijms25084174.


Response surface methodology based optimized production, purification, and characterization of L-asparaginase from Fusarium foetens.

Parashiva J, Nuthan B, Bharatha M, Praveen R, Tejashwini P, Satish S World J Microbiol Biotechnol. 2023; 39(9):252.

PMID: 37442849 DOI: 10.1007/s11274-023-03684-3.


Biochemical characterization of extremozyme L-asparaginase from Pseudomonas sp. PCH199 for therapeutics.

Darnal S, Patial V, Kumar V, Kumar S, Kumar V, Padwad Y AMB Express. 2023; 13(1):22.

PMID: 36828987 PMC: 9958223. DOI: 10.1186/s13568-023-01521-2.


References
1.
Kim B, Lee S, Kim S, Jeong H, Kwon S, Lee C . Genome sequence of an oligohaline hyperthermophilic archaeon, Thermococcus zilligii AN1, isolated from a terrestrial geothermal freshwater spring. J Bacteriol. 2012; 194(14):3765-6. PMC: 3393502. DOI: 10.1128/JB.00655-12. View

2.
Kumar N, Kishore V, Manonmani H . Chemical modification of L-asparaginase from Cladosporium sp. for improved activity and thermal stability. Prep Biochem Biotechnol. 2014; 44(5):433-50. DOI: 10.1080/10826068.2013.833110. View

3.
Taeymans D, Wood J, Ashby P, Blank I, Studer A, Stadler R . A review of acrylamide: an industry perspective on research, analysis, formation, and control. Crit Rev Food Sci Nutr. 2004; 44(5):323-47. DOI: 10.1080/10408690490478082. View

4.
Kukurova K, Morales F, Bednarikova A, Ciesarova Z . Effect of L-asparaginase on acrylamide mitigation in a fried-dough pastry model. Mol Nutr Food Res. 2009; 53(12):1532-9. DOI: 10.1002/mnfr.200800600. View

5.
Cappelletti D, Chiarelli L, Pasquetto M, Stivala S, Valentini G, Scotti C . Helicobacter pyloril-asparaginase: a promising chemotherapeutic agent. Biochem Biophys Res Commun. 2008; 377(4):1222-6. DOI: 10.1016/j.bbrc.2008.10.118. View